Home Page - Rocky Mountain Leukemia, Lymphoma & Myeloma Summit

The Rocky Mountain Leukemia, Lymphoma & Myeloma Summit is a CME-accredited educational conference convening leading hematologic oncology experts and multidisciplinary care teams in the heart of the Mountain West. Designed to serve oncology professionals across Utah, Idaho, Nevada, Colorado, Wyoming, and Montana, the Summit addresses the significant and rapidly evolving landscape of blood cancer care — bringing world-class hematologic oncology education to a region where access to subspecialty expertise has historically been limited.

The program delivers in-depth analysis of the latest clinical trial data, FDA approvals, and practice-changing advances across leukemia, lymphoma, and myeloma — spanning novel targeted therapies, next-generation immunotherapies, CAR-T and bispecific antibody platforms, and the expanding role of precision medicine in risk stratification and treatment selection. Faculty will contextualize emerging evidence within real-world practice, address the most pressing clinical controversies, and provide actionable frameworks for applying cutting-edge data to patient care in both academic and community settings. This activity is designed to improve the knowledge and clinical competence of hematology and oncology professionals to critically evaluate and apply the latest advances in leukemia, lymphoma, and myeloma — translating emerging evidence in precision medicine, novel therapeutics, and cellular therapy into optimized, individualized patient care across the Mountain West region.

Attendees will leave equipped with a current understanding of evolving treatment paradigms, practical strategies for biomarker-driven therapy selection, and the clinical confidence to integrate next-generation blood cancer therapies into everyday practice.

Binaytara is a leading global oncology 501(c)(3) nonprofit, dedicated to reducing cancer health disparities around the world. Founded in 2007 by Tara Shah and Dr. Binay Shah, our mission is to improve access to cancer care, enhance continuing medical education (CME), and foster implementation science research in hematology and oncology, thereby reducing the global burden of cancer.

As the largest cancer conference organizer in the US, we impact thousands of doctors and oncology/hematology practitioners who attend our conferences to stay current on cutting-edge treatments for their patients. Binaytara is an accredited CME provider committed to improving patient outcomes through high-quality, independent CME activities for physicians, pharmacists, and nurses.

As a leader in global oncology, we have partnered with local government and health organizations in Nepal to operate the only cancer hospital in Madhesh Province, deliver cervical cancer screenings, provide nurse training, and establish the first bone marrow transplant center in the country. In India, we have partnered with government institutions to establish hospice and palliative care programs in Madhya Pradesh. We are beginning construction in 2024 on a comprehensive 200-bed cancer center in Janakpur, Nepal that will dramatically improve access to cancer care in Nepal and surrounding communities.

We invite companies interested in improving equitable access to cancer care to support our efforts.

Hyatt Regency Salt Lake City